The prevalence and clinical characteristics of diabetic neuropathy in ...

More documents

Recommendations

Info

$Microsoft PowerPoint - S14-1_\300\374\274\272\277\317 [\310\243 ...$

$Microsoft PowerPoint - src.ppt [\310\243\310\257 \270\360\265\345]$

$Microsoft PowerPoint - S7-1_\300\374\277\353\260\374$

$Microsoft PowerPoint - src.ppt [\310\243\310\257 \270\360\265\345]$

$(Microsoft PowerPoint - WDXKRSAWSXRU.ppt [\310\243\310\257 ...$

Temporal prevalence (%) of diabetic complicationsaccording to quartile of duration of diabetes (yrs)60.050.0Neuropathy Retinopathy Nephropathy Any macroangiopathyAll P for trend < 0.0540.030.020.010.00.0Q1 (< 3.6, n = 1,033) Q2 (3.7 ~ 7.7, n = 960) Q3 (7.8 ~ 13.6, n = 969) Q4 (≥ 13.7, n = 1036)
ORs of risk factorsassociated with DPN (1)• With multivariate logisticregression analysis• Log-transformed ODs( 95% CI)A1C, hemoglobin A1C; CVD,cardiovascular disease; CVA,cerebrovascular accident; PAD, peripheralarterial disease; MNSI, MichiganNeuropathy Screening Instrument.
Page 1 and 2: The prevalence and clinicalcharacte
Page 4 and 5: •Diabetes was associated with 2-3
Page 6 and 7: Total medical cost in patients with
Page 8 and 9: DISCLOSUREAnalysis of data from the
Page 10 and 11: Prevalence of diabetic neuropathy i
Page 12 and 13: Prevalence of DPNN = 3,339Non-DPNDP
Page 14 and 15: Clinical characteristics of DPN in
Page 16 and 17: Prevalence of DPN according to thed
Page 20 and 21: ORs of risk factors associated with
Page 22 and 23: Comparison of MNSI symptom distribu
Page 24 and 25: DPN: treatmentTreatment (+) Treatme
Page 26 and 27: BPI-SF (1): Pain severityNon-DPNDPN
Page 28 and 29: MOS-sleep scale• 당신솟이 필
Page 31 and 32: EQ-5D descriptive system: 5 dimensi
Page 33 and 34: Patients awareness of DPNAwarenessY
Page 35 and 36: Investigators and study centersincl
Page 37: Thank you for your attention!

The prevalence and clinical characteristics of diabetic neuropathy in ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?